Association between eotaxin (CCL11), C-reactive protein, and antimicrobial antibodies in patients undergoing coronary angioplasty

Journal of Investigative Medicine

Volumn 54, Issue 8, 2006, Pages 446-454

  Kaehler, Jan ^a   Tuleweit, Anika ^a   Steven, Daniel ^a   Krempl, Tanja ^a   Haar, Antje ^a   Carstensen, Marion ^a   Koester, Ralf ^a   Terres, Wolfram ^b   Meinertz, Thomas ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b ALLGEMEINES KRANKENHAUS CELLE   (Germany)

Author keywords

Atherosclerosis; Chlamydia pneumoniae; Eotaxin

Indexed keywords

BACTERIUM ANTIBODY; C REACTIVE PROTEIN; EOTAXIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANTIBODY TITER; ARTICLE; ATHEROSCLEROSIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGINA; CANDIDA; CHLAMYDOPHILA PNEUMONIAE; CYTOMEGALOVIRUS; HELICOBACTER PYLORI; SIMPLEXVIRUS;

EID: 33846444905     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/6650.2006.06025     Document Type: Article

References (16)

1. Muhlestein JB, Hammond EH, Carlquist JF, et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 1996;27:1555-61.
2. Chiu B, Viira E, Tucker W, Fong IW. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 1997;96:2144-8.
3. Farsak B, Yildirir A, Akyon Y, et al. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. J Clin Microbiol 2000;38:4408-11.
4. Espinola-Klein C, Rupprecht HJ, Blankenberg S, et al. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 2002;105:15-21.
5. Prasad A, Zhu J, Halcox JP, et al. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation 2002;106:184-90.
6. Epstein S, Zhou Y, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 1999;100:e20-8.
7. Ponath PD, Qin S, Ringler DJ, et al. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 1996;97:604-12.
8. Maxion HK, Kelly KA. Chemokine expression patterns differ within anatomically distinct regions of the genital tract during Chlamydia trachomatis infection. Infect Immun 2002;70:1538-46.
9. Kodali RB, Kim WJ, Galaria II, et al. CCL11 (eotaxin) induces CCR3-dependent smooth muscle cell migration. Arterioscler Thromb Vasc Biol 2004;24:1211-6.
10. Committee on Percutaneous Transluminal Coronary Angioplasty. Guidelines for percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1993;7:2033-54.
11. Holmes D, Hirshfeld J, Faxon D, et al. Coronary artery stents. J Am Coll Cardiol 1998;32:1471-82.
12. Haley KJ, Lilly CM, Yang JH, et al. Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation. Circulation 2000;102:2185-9.
13. Kuo C, Shor A, Campbell L, et al. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993;167:841-9.
14. Grayston J, Kuo C, Coulson A, et al. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 1995;92:3397-400.
15. Yamamoto K, Takanashi S, Hasegawa Y, et al. Eotaxin level in induced sputum is increased in patients with bronchial asthma and in smokers. Respiration 2003;70:600-5.
16. Zee RY, Cook NR, Cheng S, et al. Multi-locus candidate gene polymorphisms and risk of myocardial infarction: a population-based, prospective genetic analysis. J Thromb Haemost 2006;4:341-8.